| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZILSARTAN MEDOXOMIL | 214489 | 001 | ANDA | AZILSARTAN KAMEDOXOMIL | TABLET;ORAL | EQ 40MG MEDOXOMIL | No | No | 2022/07/20 | 2022/07/20 | LUPIN LTD | Discontinued |
| AZILSARTAN MEDOXOMIL | 214489 | 002 | ANDA | AZILSARTAN KAMEDOXOMIL | TABLET;ORAL | EQ 80MG MEDOXOMIL | No | No | 2022/07/20 | 2022/07/20 | LUPIN LTD | Discontinued |
| AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE | 217490 | 001 | ANDA | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE | TABLET;ORAL | EQ 40MG MEDOXOMIL;12.5MG | No | No | 2025/01/21 | 2025/01/21 | ALKEM LABS LTD | Prescription |
| AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE | 217490 | 002 | ANDA | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE | TABLET;ORAL | EQ 40MG MEDOXOMIL;25MG | No | No | 2025/01/21 | 2025/01/21 | ALKEM LABS LTD | Prescription |
| AZILSARTAN MEDOXOMIL | 219062 | 001 | ANDA | AZILSARTAN MEDOXOMIL | TABLET | 80MG | No | No | 2025/03/19 (TA) | -- | HETERO LABS LIMITED | None (Tentative Approval) |
| AZILSARTAN MEDOXOMIL | 219062 | 002 | ANDA | AZILSARTAN MEDOXOMIL | TABLET | 40MG | No | No | 2025/03/19 (TA) | -- | HETERO LABS LIMITED | None (Tentative Approval) |
| AZILSARTAN MEDOXOMIL | 219062 | 003 | ANDA | AZILSARTAN MEDOXOMIL | TABLET | 20MG | No | No | 2025/03/19 (TA) | -- | HETERO LABS LIMITED | None (Tentative Approval) |
符合检索条件的记录共 7 条
共 1 页，当前第 1 页
返回检索页
可点击列名称排序
可点击列名称排序